Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 31, 2005
Gene expression profile of activated microglia under conditions associated with dopamine neuronal damageDavid M Thomas, Dina M Francescutti-Verbeem, Donald M Kuhn
Annals of the New York Academy of Sciences|November 11, 2008
Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicityDonald M Kuhn, Dina M Francescutti-Verbeem, David M Thomas
Journal of Neurochemistry|December 20, 2007
The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicityDavid M Thomas, Dina M Francescutti-Verbeem, Donald M Kuhn
Journal of Neurochemistry|May 22, 2009
Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicityDavid M Thomas, Dina M Francescutti-Verbeem, Donald M Kuhn
Journal of Pain and Symptom Management|January 19, 2008
Use of ketamine for ischemic pain in end-stage renal failureMargred M Capel, Rhian Jenkins, Melanie Jefferson, et al.
Annals of the New York Academy of Sciences|November 16, 2006
Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damageDonald M Kuhn, Dina M Francescutti-Verbeem, David M Thomas
Pharmacogenomics|September 13, 2013
Multiomics medicine in oncology: assessing effectiveness, cost-effectiveness and future research priorities for the molecularly unique individualBrett Doble, Anthony Harris, David M Thomas, et al.
Nature Reviews. Cancer|October 17, 2014
Translational biology of osteosarcomaMaya Kansara, Michele W Teng, Mark J Smyth, et al.
Cancer Biology & Therapy|May 17, 2003
Role of the retinoblastoma protein in differentiation and senescenceDavid M Thomas, Hai-Su Yang, Kamilah Alexander, et al.
Sarcoma|January 4, 2011
Targeting the p53 Pathway in Ewing SarcomaPaul M Neilsen, Kathleen I Pishas, David F Callen, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 31, 2005
Gene expression profile of activated microglia under conditions associated with dopamine neuronal damageDavid M Thomas, Dina M Francescutti-Verbeem, Donald M Kuhn
Annals of the New York Academy of Sciences|November 11, 2008
Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicityDonald M Kuhn, Dina M Francescutti-Verbeem, David M Thomas
Journal of Neurochemistry|December 20, 2007
The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicityDavid M Thomas, Dina M Francescutti-Verbeem, Donald M Kuhn
Journal of Neurochemistry|May 22, 2009
Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicityDavid M Thomas, Dina M Francescutti-Verbeem, Donald M Kuhn
Journal of Pain and Symptom Management|January 19, 2008
Use of ketamine for ischemic pain in end-stage renal failureMargred M Capel, Rhian Jenkins, Melanie Jefferson, et al.
Annals of the New York Academy of Sciences|November 16, 2006
Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damageDonald M Kuhn, Dina M Francescutti-Verbeem, David M Thomas
Pharmacogenomics|September 13, 2013
Multiomics medicine in oncology: assessing effectiveness, cost-effectiveness and future research priorities for the molecularly unique individualBrett Doble, Anthony Harris, David M Thomas, et al.
Nature Reviews. Cancer|October 17, 2014
Translational biology of osteosarcomaMaya Kansara, Michele W Teng, Mark J Smyth, et al.
Cancer Biology & Therapy|May 17, 2003
Role of the retinoblastoma protein in differentiation and senescenceDavid M Thomas, Hai-Su Yang, Kamilah Alexander, et al.
Sarcoma|January 4, 2011
Targeting the p53 Pathway in Ewing SarcomaPaul M Neilsen, Kathleen I Pishas, David F Callen, et al.
Pageof 22